(Q36979956)

17 August 2017

1 reference

title

The role of interleukin-6 in insulin resistance, body fat distribution and energy balance (English)

1 reference

17 August 2017

1 reference

1

Hoene M

1 reference

17 August 2017

2

Weigert C

1 reference

17 August 2017

23 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

9

1 reference

17 August 2017

1

1 reference

17 August 2017

20-29

1 reference

The metabolic syndrome: a global public health problem and a new definition

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Prevalence of overweight and obesity in the United States, 1999-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Marked cell-type-specific differences in glycosylation of human interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

IL-6 signal transduction and its physiological roles: the signal orchestration model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Molecular phylogeny within type I cytokines and their cognate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Soluble cytokine receptors are present in normal human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Soluble receptors for cytokines and growth factors: generation and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Cytokines and the hepatic acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Searching for the exercise factor: is IL-6 a candidate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Regulation of adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Cytokine response to eccentric exercise in young and elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The anti-inflammatory effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Reduced exercise endurance in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 gene polymorphism and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Defective inflammatory response in interleukin 6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Antioxidants attenuate the plasma cytokine response to exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Acquiring signalling specificity from the cytokine receptor gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Overlapping and distinct signals through leptin receptor (OB-R) and a closely related cytokine signal transducer, gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Congenital leptin deficiency is associated with severe early-onset obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

gp130 receptor ligands as potential therapeutic targets for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Hormonal regulation of interleukin-6 production in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00410.X

10.1111/J.1467-789X.2007.00410.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17956545